AMTAGVI
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88918260
- Registration number
- 7588640
- Mark type
- Stylized text
- Filed
- 15 May 2020
- Published for opposition
- 29 Sept 2020
- Registered
- 03 Dec 2024
- Attorney of record
- Carla B. Oakley
Goods and services
- Class 005 — Pharmaceuticals: biological preparations for the treatment of immune system related and oncological diseases and disorders
- Class 044 — Medical, beauty and agricultural services: providing medical information relating to oncology and immunotherapy treatment; providing medical information; medical consultations; isolation and collection of human biological tissue for immunotherapy
Owner
- Iovance Biotherapeutics, Inc., San Carlos, CA, US
- Iovance Biotherapeutics, Inc., San Carlos, CA, US
- Iovance Biotherapeutics, Inc., San Carlos, CA, US
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Nov 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Oct 2024 — ASSIGNED TO LIE
- 01 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Apr 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 08 Apr 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 11 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Jan 2024 — NON-FINAL ACTION E-MAILED
- 11 Jan 2024 — SU - NON-FINAL ACTION - WRITTEN
- 27 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Nov 2023 — USE AMENDMENT FILED